Subscribe to our newsletter to receive the latest product updates and special offers

HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite
Theme 		Help
Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#181 / 200 Total
ENLV - Enlivex Therapeutics Ltd - Stock Price Chart
TickerENLV [NASD]
CompanyEnlivex Therapeutics Ltd
CountryIsrael
IndustryBiotechnology
Market Cap30.12MEPS (ttm)-1.56
P/E-EPS this Y44.87%
Forward P/E-EPS next Y36.05%
PEG-EPS past 5Y32.51%
P/S-EPS next 5Y-
P/B1.00EPS Q/Q-25.32%
Dividend-Sales Q/Q-
Insider Own19.44%Inst Own1.74%
Insider Trans0.00%Inst Trans-13.30%
Short Float1.86%Earnings-
Analyst Recom1.00Target Price7.00
Avg Volume180.06K52W Range1.15 - 4.59
Apr-29-24 08:00AM Enlivex CEO Issues Letter to Shareholders Perspectives on Recent Events (GlobeNewswire) +15.28%
Apr-22-24 08:00AM Enlivex Announces Dosing of First Two Patients in its Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis (GlobeNewswire)
Apr-16-24 07:50AM Enlivex Announces Authorization from the Danish Regulatory Agency for the Company's Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis (GlobeNewswire) +11.54%
Apr-15-24 01:01PM Enlivex (ENLV) Stock Plummets 51% in a Week: Here's Why (Zacks) -17.72%
Apr-11-24 02:58PM Enlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from Its Phase II Trial Evaluating Allocetra In Patients with Sepsis (GlobeNewswire) -54.02%
08:05AM Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra In Patients With Sepsis (GlobeNewswire)
Apr-05-24 07:52AM ENLV Stock Earnings: Enlivex Therapeutics Misses EPS for Q4 2023 (InvestorPlace) +6.38%
Mar-22-24 10:50AM Enlivex Therapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV (ACCESSWIRE)
Feb-26-24 08:30AM Enlivex Receives Regulatory Authorization From Israel's Health Ministry For The Initiation Of Phase 1/2 Trial Evaluating Allocetra In Patients With Knee Osteoarthritis (ACCESSWIRE)
Feb-21-24 08:30AM Enlivex Completes Enrollment Of All 120 Patients In Phase 2 Trial Of Allocetra In Patients With Sepsis, Third-Leading Cause Of Mortality In US Hospitals (ACCESSWIRE)
UPC - Universe Pharmaceuticals INC - Stock Price Chart
TickerUPC [NASD]
CompanyUniverse Pharmaceuticals INC
CountryChina
IndustryDrug Manufacturers - Specialty & Generic
Market Cap7.92MEPS (ttm)-1.70
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S0.25EPS next 5Y-
P/B0.20EPS Q/Q47.96%
Dividend-Sales Q/Q-13.17%
Insider Own57.05%Inst Own0.18%
Insider Trans0.00%Inst Trans-97.12%
Short Float0.25%EarningsJan 30/a
Analyst Recom-Target Price-
Avg Volume101.47K52W Range0.75 - 5.88
Feb-20-24 08:32AM Why Is Universe Pharmaceuticals (UPC) Stock Down 29% Today? (InvestorPlace) -28.46%
Jan-30-24 04:30PM Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results (PR Newswire) -14.64%
Aug-04-23 08:30AM Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares (GlobeNewswire) -6.83%
Jul-27-23 10:15AM Universe Pharmaceuticals INC Announces Share Consolidation (GlobeNewswire) +6.33%
Mar-07-23 08:00AM Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency (GlobeNewswire)
Dec-21-22 08:00AM Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19 (GlobeNewswire)
Nov-14-22 08:00AM Universe Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price Requirement (GlobeNewswire)
Aug-16-22 08:00AM Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022 (PR Newswire)
Jul-19-22 06:00AM Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency (GlobeNewswire)
Mar-30-22 08:00AM Universe Pharmaceuticals INC Announces Strategic Partnership with Lian-Ou Health to Develop its Digital Marketing and Sales on E-Commerce Platforms (GlobeNewswire)
GVP - GSE Systems, Inc. - Stock Price Chart
TickerGVP [NASD]
CompanyGSE Systems, Inc.
CountryUSA
IndustrySoftware - Application
Market Cap7.78MEPS (ttm)-3.54
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-81.20%
P/S0.17EPS next 5Y-
P/B1.36EPS Q/Q-19.86%
Dividend-Sales Q/Q-5.56%
Insider Own22.88%Inst Own10.89%
Insider Trans0.00%Inst Trans6.01%
Short Float1.97%EarningsApr 01/a
Analyst Recom1.00Target Price13.00
Avg Volume49.99K52W Range1.21 - 6.77
Apr-30-24 05:32PM GSE Solutions Announces Management Transition (PR Newswire)
Apr-16-24 09:00AM GSE Solutions Awarded $765K Contract for Nuclear Engineering Services for a 24-month Fuel Cycle Operation (PR Newswire) -10.00%
Apr-03-24 09:24AM GSE Systems, Inc. (NASDAQ:GVP) Q4 2023 Earnings Call Transcript (Insider Monkey) +13.86%
Apr-02-24 06:29AM Q4 2023 GSE Systems Inc Earnings Call (Thomson Reuters StreetEvents) +13.62%
Apr-01-24 08:53PM GVP Stock Earnings: GSE Systems Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
04:05PM GSE Systems Reports Fourth Quarter and Fiscal 2023 Financial Results (PR Newswire)
Mar-25-24 04:05PM GSE Solutions Schedules Release of Fourth Quarter and Fiscal 2023 Financial Results and Conference Call (PR Newswire)
Nov-15-23 01:34PM GSE Systems, Inc. (NASDAQ:GVP) Q3 2023 Earnings Call Transcript (Insider Monkey) -5.41%
Nov-14-23 04:05PM GSE Systems Reports Third Quarter 2023 Financial Results (PR Newswire) +9.12%
Nov-09-23 09:00AM Southeast Texas Nuclear Power Supplier Selects GSE Solutions as a Preferred Engineering Services Provider (PR Newswire) -10.40%
BRFH - Barfresh Food Group Inc - Stock Price Chart
TickerBRFH [NASD]
CompanyBarfresh Food Group Inc
CountryUSA
IndustryBeverages - Non-Alcoholic
Market Cap25.91MEPS (ttm)-0.21
P/E-EPS this Y61.90%
Forward P/E-EPS next Y25.00%
PEG-EPS past 5Y23.29%
P/S3.19EPS next 5Y-
P/B10.14EPS Q/Q66.57%
Dividend-Sales Q/Q34.31%
Insider Own50.97%Inst Own11.67%
Insider Trans0.00%Inst Trans1.30%
Short Float0.94%EarningsFeb 29/a
Analyst Recom1.00Target Price3.00
Avg Volume822.77K52W Range1.00 - 2.39
May-01-24 09:45AM Barfresh Announces Appointment of Marko Matla as Vice President of Supply Chain & Co-Manufacturing (GlobeNewswire) +20.62%
Apr-30-24 04:05PM Barfresh to Host Business Update Call on May 15, 2024 (GlobeNewswire)
Apr-26-24 10:06AM Barfresh Highlights Many New Wins With its Smoothies in the Education Channel (GlobeNewswire) -22.53%
Apr-02-24 12:53PM BRFH Stock Earnings: Barfresh Food Group Misses EPS, Misses Revenue for Q4 2023 (InvestorPlace)
Mar-14-24 10:12AM 16 Largest Soda and Soft Drink Companies in The World (Insider Monkey)
Mar-06-24 08:15AM Barfresh Food Group, Inc. (NASDAQ:BRFH) Q4 2023 Earnings Call Transcript (Insider Monkey)
Feb-29-24 04:05PM Barfresh Provides Fourth Quarter and Full Year 2023 Results and Business Update (GlobeNewswire) +5.62%
Feb-15-24 08:30AM Barfresh to Host Business Update Call on February 29, 2024 (GlobeNewswire)
Nov-01-23 11:50AM Barfresh Regains Compliance With Nasdaq Stockholders Equity Requirement (GlobeNewswire)
Oct-26-23 04:05PM Barfresh Provides Third Quarter 2023 Results and Business Update (GlobeNewswire) -5.98%
AKA - a.k.a. Brands Holding Corp - Stock Price Chart
TickerAKA [NYSE]
Companya.k.a. Brands Holding Corp
CountryUSA
IndustryInternet Retail
Market Cap204.75MEPS (ttm)-9.25
P/E-EPS this Y81.74%
Forward P/E-EPS next Y17.63%
PEG-EPS past 5Y-
P/S0.37EPS next 5Y-
P/B1.39EPS Q/Q91.93%
Dividend-Sales Q/Q-0.14%
Insider Own91.83%Inst Own0.44%
Insider Trans0.00%Inst Trans28.45%
Short Float8.15%EarningsMay 08/a
Analyst Recom2.60Target Price11.12
Avg Volume6.79K52W Range3.60 - 19.10
Apr-24-24 08:00AM a.k.a. Brands Holding Corp. to Report First Quarter 2024 Financial Results on May 8, 2024 (Business Wire) +6.87%
Mar-13-24 04:05PM Culture Kings Returns as an Official Partner of Rolling Loud California (Business Wire) -8.09%
Mar-08-24 10:17AM a.k.a. Brands Holding Corp. (NYSE:AKA) Q4 2023 Earnings Call Transcript (Insider Monkey) -12.32%
Mar-07-24 10:42PM a.k.a. Brands Holding Corp (AKA) Navigates Challenging Year with Strategic Debt Reduction and U. ... (GuruFocus.com)
09:53PM AKA Stock Earnings: a.k.a. Brands Holding Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
06:05PM A.k.a. Brands (AKA) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
05:35PM a.k.a. Brands Holding Corp. Grows on U.S. Net Sales on Q4 2023 (Exec Edge)
04:05PM a.k.a. Brands Holding Corp. Reports Fourth Quarter and Full Year 2023 Financial Results (Business Wire)
Feb-22-24 08:00AM a.k.a. Brands Holding Corp. to Report Fourth Quarter and Fiscal 2023 Financial Results on March 7, 2024 (Business Wire)
Jan-18-24 01:04PM Hear from Ciaran Long, CFO of a.k.a. Brands Live at ICR Conference 2024 (IPO-Edge.com) +8.50%
JANX - Janux Therapeutics Inc - Stock Price Chart
TickerJANX [NASD, RUT]
CompanyJanux Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap3.23BEPS (ttm)-1.34
P/E-EPS this Y-13.64%
Forward P/E-EPS next Y-9.25%
PEG-EPS past 5Y-92.62%
P/S399.15EPS next 5Y-
P/B8.39EPS Q/Q34.79%
Dividend-Sales Q/Q-13.50%
Insider Own33.35%Inst Own57.84%
Insider Trans17.37%Inst Trans1.30%
Short Float10.00%EarningsMar 08/a
Analyst Recom1.00Target Price58.50
Avg Volume1.00M52W Range5.65 - 61.00
Apr-30-24 08:50AM Here's What Could Help Janux Therapeutics (JANX) Maintain Its Recent Price Strength (Zacks)
Apr-25-24 11:28AM 11 Oversold MidCap Stocks To Buy Now (Insider Monkey)
Apr-17-24 01:12PM Take the Money and Run: 3 Overbought Stocks to Sell ASAP (InvestorPlace) -5.12%
Apr-16-24 01:19PM These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come? (InvestorPlace)
Apr-15-24 12:54PM Janux (JANX) Rises Almost 50% in a Week on Buyout Rumors (Zacks)
Apr-12-24 08:50AM Janux Therapeutics (JANX) is on the Move, Here's Why the Trend Could be Sustainable (Zacks) +5.30%
05:40AM Why Janux Therapeutics Stock Is Crushing It This Week (Motley Fool)
Apr-11-24 04:19PM Biotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options (Investor's Business Daily) +12.06%
02:13PM Why Is Cancer-Focused Janux Therapeutics Stock Trading Higher On Thursday? (Benzinga)
09:55AM Wall Street Analysts Think Janux Therapeutics (JANX) Could Surge 40.3%: Read This Before Placing a Bet (Zacks)
CING - Cingulate Inc - Stock Price Chart
TickerCING [NASD]
CompanyCingulate Inc
CountryUSA
IndustryBiotechnology
Market Cap4.46MEPS (ttm)-30.39
P/E-EPS this Y86.02%
Forward P/E-EPS next Y3.85%
PEG-EPS past 5Y-24.19%
P/S-EPS next 5Y-
P/B-EPS Q/Q27.06%
Dividend-Sales Q/Q-
Insider Own40.04%Inst Own0.12%
Insider Trans0.00%Inst Trans-76.96%
Short Float0.58%EarningsApr 01/b
Analyst Recom2.00Target Price22.00
Avg Volume269.45K52W Range0.75 - 23.40
Apr-30-24 05:45AM Peter J. Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board Member, to be Featured with Chairman and CEO Shane J. Schaffer on Benzinga All Live Access (GlobeNewswire)
Apr-29-24 09:00AM Keynotes, Educational Panels and 96 Companies to Present at the Planet MicroCap Showcase: VEGAS on April 30 - May 2, 2024 at the Paris Hotel & Casino in Las Vegas, NV (ACCESSWIRE)
Apr-16-24 05:00PM Cingulate to Participate in Planet MicroCap Showcase: Vegas 2024 (GlobeNewswire)
Apr-01-24 08:00AM Cingulate Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update (GlobeNewswire)
Mar-19-24 04:45PM Cingulate to Participate in Benzinga All Live Access Event (GlobeNewswire)
Mar-06-24 06:45AM Cingulate to Attend DCAT Week 2024 in New York City (GlobeNewswire)
Feb-13-24 06:45AM Cingulate Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board of Directors (GlobeNewswire)
Feb-06-24 04:15PM Cingulate Announces Closing of $7.5 Million Public Offering (GlobeNewswire)
Feb-02-24 09:15AM Cingulate Announces Pricing of $7.5 Million Public Offering (GlobeNewswire) -60.42%
Jan-29-24 08:00AM Longtime Cingulate Controller Jennifer Callahan Promoted to CFO (GlobeNewswire) -11.59%
LYRA - Lyra Therapeutics Inc - Stock Price Chart
TickerLYRA [NASD]
CompanyLyra Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap276.60MEPS (ttm)-1.25
P/E-EPS this Y-2.25%
Forward P/E-EPS next Y6.47%
PEG-EPS past 5Y-21.63%
P/S164.64EPS next 5Y-1.60%
P/B3.64EPS Q/Q20.51%
Dividend-Sales Q/Q29.76%
Insider Own23.67%Inst Own60.77%
Insider Trans0.18%Inst Trans-0.19%
Short Float0.73%EarningsApr 30/a
Analyst Recom1.00Target Price12.20
Avg Volume360.60K52W Range2.36 - 6.79
Apr-30-24 09:56PM LYRA Stock Earnings: Lyra Therapeutics Misses EPS, Beats Revenue for Q1 2024 (InvestorPlace) +9.09%
05:30PM Lyra Therapeutics, Inc. (LYRA) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:04PM Lyra Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update (GlobeNewswire)
Apr-26-24 04:51PM Lyra Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire) -8.70%
Mar-28-24 07:08AM Lyra Therapeutics (LYRA) Soars 6.5%: Is Further Upside Left in the Stock? (Zacks)
Mar-25-24 08:50AM Lyra Therapeutics (LYRA) Is a Great Choice for 'Trend' Investors, Here's Why (Zacks)
Mar-23-24 05:31AM Lyra Therapeutics Inc (LYRA) Posts Year-End Financial Results, Aligns with EPS Projections (GuruFocus.com)
Mar-22-24 09:55AM Wall Street Analysts See a 101.81% Upside in Lyra Therapeutics (LYRA): Can the Stock Really Move This High? (Zacks)
Mar-21-24 10:54PM LYRA Stock Earnings: Lyra Therapeutics Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
04:01PM Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update (GlobeNewswire)
GAME - GameSquare Holdings Inc - Stock Price Chart
TickerGAME [NASD]
CompanyGameSquare Holdings Inc
CountryCanada
IndustryElectronic Gaming & Multimedia
Market Cap17.80MEPS (ttm)-4.65
P/E-EPS this Y89.79%
Forward P/E-EPS next Y82.76%
PEG-EPS past 5Y62.42%
P/S0.38EPS next 5Y-
P/B0.51EPS Q/Q89.87%
Dividend-Sales Q/Q41.06%
Insider Own52.60%Inst Own10.46%
Insider Trans0.00%Inst Trans-
Short Float1.56%EarningsApr 16/a
Analyst Recom1.00Target Price5.00
Avg Volume124.23K52W Range1.23 - 4.69
Today 08:00AM GameSquare's Stream Hatchet Publishes 2024 First Quarter Report (ACCESSWIRE)
Apr-30-24 08:00AM GameSquare and Dairy MAX Partner to Launch UEFN World Building Map Campaign in Fortnite's Farm Tycoon (ACCESSWIRE) -5.96%
Apr-19-24 08:11AM Engine Gaming and Media, Inc. (NASDAQ:GAME) Q4 2023 Earnings Call Transcript (Insider Monkey)
Apr-17-24 08:45AM Engine Gaming and Media, Inc. (NASDAQ:GAME) Q4 2024 Earnings Call Transcript (Insider Monkey) -27.41%
Apr-16-24 04:05PM GameSquare Holdings Reports 2023 Results (ACCESSWIRE) -10.25%
Apr-11-24 08:00AM GameSquare to Report Q4 2023 Financial Results on April 16, 2024 (ACCESSWIRE)
Mar-28-24 04:05PM GameSquare Announces Completion of Voluntary Delisting from the TSXV on March 28, 2024 (ACCESSWIRE)
Mar-22-24 04:15PM GameSquare Announces Voluntary Delisting from the TSXV (ACCESSWIRE) -7.17%
Mar-21-24 07:00AM FaZe Clan is Building a Licensing Empire at Retailers Across the Nation (ACCESSWIRE) +7.72%
Mar-14-24 07:00AM GameSquare's Stream Hatchet Redefines Gaming Intelligence with New AI-Powered News Platform and Redesigned Website (ACCESSWIRE)
OMGA - Omega Therapeutics Inc - Stock Price Chart
TickerOMGA [NASD, RUT]
CompanyOmega Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap152.24MEPS (ttm)-1.81
P/E-EPS this Y34.76%
Forward P/E-EPS next Y0.54%
PEG-EPS past 5Y-48.08%
P/S49.11EPS next 5Y-
P/B2.62EPS Q/Q43.04%
Dividend-Sales Q/Q34.56%
Insider Own62.98%Inst Own29.89%
Insider Trans0.00%Inst Trans0.24%
Short Float21.70%EarningsMar 28/b
Analyst Recom1.00Target Price11.00
Avg Volume395.35K52W Range1.30 - 10.09
Apr-25-24 10:02AM Omega Therapeutics, Inc. (OMGA) Expected to Beat Earnings Estimates: Can the Stock Move Higher? (Zacks)
Apr-23-24 07:00AM Omega Therapeutics to Present New Preclinical Data on Epigenomic Upregulation at the American Society of Gene and Cell Therapy 27th Annual Meeting (GlobeNewswire)
Apr-17-24 09:55AM Omega Therapeutics (OMGA) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now (Zacks) +6.02%
Apr-09-24 07:00AM Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision Epigenomic Control (GlobeNewswire)
Apr-08-24 08:00AM Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences (PR Newswire)
Apr-03-24 12:00PM Omega Therapeutics (OMGA) Upgraded to Buy: Here's What You Should Know (Zacks)
Mar-28-24 11:54PM OMGA Stock Earnings: Omega Therapeutics Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace)
10:25AM Omega Therapeutics, Inc. (OMGA) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
09:15AM Omega Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Strategic Update (GlobeNewswire)
Mar-19-24 08:30AM Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024 (PR Newswire)
1⋯10⋯14151617181920
affiliate • advertise • toggle light mode • contact • privacy • help
do not sell my data • privacy settings
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2024 FINVIZ.com. All Rights Reserved.